Samsung to invest $22.3 billion in AI, 5G, auto electronics and biopha
US expansion matter of when, not if: Samsung Biologics
GSK partners with Samsung Biologics to secure additional manufacturing capacity for innovative biopharmaceutical portfolio | World Pharma Today
Samsung Biologics looks to drive Big Pharma to outsource bioproduction
Samsung Biologics new IPO could be valued at $2.6 billion - Medical Design and Outsourcing
Samsung Pharmaceutical Arm Samsung BioLogics Fined For $4 Billion Accounts Breach
PharmaBoardroom - Korea Pharma News: Samsung Bioepis Goes Down Under; Blockchain-Based Vaccine Certificates; The First Korean Blockbuster?
Samsung Pharm Hyaluronic Acid 500mg x 60tabs
Company News | Newsroom | SAMSUNG BIOLOGICS
Samsung BioLogics: The story of the world's largest biologics manufacturing facility
Samsung Biologics wins $897 mn in two deals with Pfizer - KED Global
Samsung Pharm-Kor Co.,Ltd | LinkedIn
Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurmas portfolio companies | World Pharma Today
Company News | Newsroom | SAMSUNG BIOLOGICS
Enzolytics and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibody Therapies | World Pharma Today
Reaching qualified pharma audiences with efficiency | Success Stories | Resources | Samsung Ads
Samsung Biologics bumps Hyundai from Korean market's top 3 - Nikkei Asia
Samsung Pharmaceutical - Crunchbase Company Profile & Funding
Samsung Biologics' Biopharmaceutical Manufacturing Facility, Songdo
Science & Technology | Newsroom | SAMSUNG BIOLOGICS
Samsung Biologics - Wikipedia
Samsung Biologics seals $411million long-term contract with Pfizer < Pharma < Article - KBR
Samsung Biologics completes full acquisition of Samsung Bioepis | World Pharma Today
Samsung BioLogics signs $55-million contract with India's Sun Pharma < Pharma < Article - KBR
